Asymmetric Enzymatic Glycosylation of Mitoxantrone
Authors:
- 29 April 2011
- journal article
- letter
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 13 (10) , 2786-2788
Abstract
Using a uniquely promiscuous engineered glycosyltransferase (GT) derived from the macrolide-inactivating GT OleD, a single-step asymmetric glucosylation of one ‘arm’ of the drug mitoxantrone was efficiently achieved in high stereo- and regiospecificity. The synthesis, structural elucidation, and anticancer activity of the corresponding mitoxantrone 4′-β-d-glucoside are described.Keywords
This publication has 45 references indexed in Scilit:
- Recombinant E. coli Prototype Strains for in Vivo GlycorandomizationACS Chemical Biology, 2010
- Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis [RETIRED]Neurology, 2010
- Probing the Aglycon Promiscuity of an Engineered GlycosyltransferaseAngewandte Chemie International Edition, 2008
- The in vitro Characterization of Polyene Glycosyltransferases AmphDI and NysDIChemBioChem, 2008
- Optimizing Glycosyltransferase Specificity via “Hot Spot” Saturation Mutagenesis Presents a Catalyst for Novobiocin GlycorandomizationChemistry & Biology, 2008
- Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agentNucleic Acids Research, 2007
- The crystal structure of two macrolide glycosyltransferases provides a blueprint for host cell antibiotic immunityProceedings of the National Academy of Sciences, 2007
- The structure of PknB in complex with mitoxantrone, an ATP‐competitive inhibitor, suggests a mode of protein kinase regulation in mycobacteriaFEBS Letters, 2006
- MitoxantroneCNS Drugs, 2004
- Creation of the first anomeric D/L-sugar kinase by means of directed evolutionProceedings of the National Academy of Sciences, 2003